Search
UK MHRA guidance: National Assessment Procedure for Medicines
The National Assessment Procedure for Medicines provides a framework for UK-wide marketing authorisation applications assessed through the national procedure. It covers applications for innovative and established medicines, including submission requirements, assessment stages, timelines, requests for information, Commission on Human Medicines involvement, and regulatory decisions. Introduction The national assessment procedure applies to UK-wide marketing authorisation applic
Sharan Murugan
6 days ago5 min read
UK MHRA Guidance: Navigating the UK National Assessment
Understanding and navigating the UK's regulatory requirements is crucial for pharmaceutical companies aiming to obtain marketing...
Sharan Murugan
May 22, 20252 min read